You are here
EPPIN PHARMA INC
UEI: VHJQLGNL9T58
# of Employees: 2
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
EP055, a non-hormonal male contraceptive:IND-enabling studies
Amount: $1,295,135.00The global contraceptives market was valued at $24BN in 2018 and is expected to grow at a CAGR of 6.9% from 2019 to 2027. The contraceptive market consists of short-term methods such as condoms, oral ...
SBIRPhase II2021Department of Health and Human Services National Institutes of Health -
Drug Interactions in vitro for EP055: a Non-Hormonal Male Contraceptive
Amount: $225,000.00Project Summary The global contraceptives market was valued at $billion inand is expected to grow at a CAGR offromtoto reach an estimated value of $billion inThe contraceptive market consists of short ...
SBIRPhase I2019Department of Health and Human Services National Institutes of Health -
Testing a male oral contraceptive targeting Eppin
Amount: $1,832,621.00The global contraceptives market was valued at $billion inand is expected to grow at a CAGR offromtoto reach an estimated value of $billion inThe contraceptive market consists of short term methods su ...
STTRPhase II2018Department of Health and Human Services National Institutes of Health -
Contraceptive testing for semen availability in male monkeys
Amount: $225,000.00DESCRIPTION provided by applicant The global contraceptives market was valued at $ billion in and is expected to grow at a CAGR of from to to reach an estimated value of $ ...
STTRPhase I2015Department of Health and Human Services National Institutes of Health